Having developed a number of innovative, ethical drugs (ETC) in the circulatory, digestive, anticancer, metabolic, and renal fields ever since its foundation, inno.N immensely contributes to improving the quality of life for humanity based on its competitive pipeline of novel drugs, including the global novel drug of ‘K-CAB Tab.,’ as well as biological drugs and incrementally modified drug.
Our company provides customized services for each Advanced Therapy Medicinal Products (ATMPs) development processes based on our cell culture technologies, which are the key to biological drugs development, strict quality control, and GMP manufacturing systems.